×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NEO – neogenomics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NEO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/2
09:23 am
neo
3 of Wall Street's Favorite Stocks We Think Twice About [Yahoo! Finance]
Medium
Report
3 of Wall Street's Favorite Stocks We Think Twice About [Yahoo! Finance]
3/23
06:44 am
neo
2 High-Flying Stocks to Consider Right Now and 1 That Underwhelm [Yahoo! Finance]
Low
Report
2 High-Flying Stocks to Consider Right Now and 1 That Underwhelm [Yahoo! Finance]
3/18
04:35 pm
neo
NeoGenomics (NEO) Launches RaDaR ST to Capture Share in $20B MRD Market [Yahoo! Finance]
Low
Report
NeoGenomics (NEO) Launches RaDaR ST to Capture Share in $20B MRD Market [Yahoo! Finance]
3/16
09:21 pm
neo
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know [Yahoo! Finance]
Low
Report
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know [Yahoo! Finance]
3/16
12:08 pm
neo
NeoGenomics (NEO) had its "buy" rating reaffirmed by TD Cowen.
Low
Report
NeoGenomics (NEO) had its "buy" rating reaffirmed by TD Cowen.
3/16
12:08 pm
neo
NeoGenomics (NEO) had its "market perform" rating reaffirmed by William Blair.
Low
Report
NeoGenomics (NEO) had its "market perform" rating reaffirmed by William Blair.
3/16
07:18 am
neo
NeoGenomics' PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling [Yahoo! Finance]
Low
Report
NeoGenomics' PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling [Yahoo! Finance]
3/16
07:05 am
neo
NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
Medium
Report
NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/27
10:52 am
neo
Form SCHEDULE 13G/A NEOGENOMICS INC Filed by: VANGUARD GROUP INC
Medium
Report
Form SCHEDULE 13G/A NEOGENOMICS INC Filed by: VANGUARD GROUP INC
3/3
06:17 pm
neo
Form 4 NEOGENOMICS INC For: Mar 01 Filed by: Aunan Greg D
Low
Report
Form 4 NEOGENOMICS INC For: Mar 01 Filed by: Aunan Greg D
3/3
06:16 pm
neo
Form 4 NEOGENOMICS INC For: Mar 01 Filed by: Olivo Alicia C
Low
Report
Form 4 NEOGENOMICS INC For: Mar 01 Filed by: Olivo Alicia C
3/3
06:16 pm
neo
Form 4 NEOGENOMICS INC For: Mar 01 Filed by: Stone Warren
Low
Report
Form 4 NEOGENOMICS INC For: Mar 01 Filed by: Stone Warren
3/3
06:16 pm
neo
Form 4 NEOGENOMICS INC For: Mar 01 Filed by: Zook Anthony P.
Low
Report
Form 4 NEOGENOMICS INC For: Mar 01 Filed by: Zook Anthony P.
3/2
05:03 pm
neo
Form 3 NEOGENOMICS INC For: Mar 02 Filed by: Jain Abhishek
Low
Report
Form 3 NEOGENOMICS INC For: Mar 02 Filed by: Jain Abhishek
2/24
04:15 pm
neo
Form 4 NEOGENOMICS INC For: Feb 21 Filed by: Olivo Alicia C
Low
Report
Form 4 NEOGENOMICS INC For: Feb 21 Filed by: Olivo Alicia C
2/24
04:15 pm
neo
Form 4 NEOGENOMICS INC For: Feb 21 Filed by: Stone Warren
Low
Report
Form 4 NEOGENOMICS INC For: Feb 21 Filed by: Stone Warren
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Form 4 NEOGENOMICS INC For: Mar 13 Filed by: JONES STEVEN C
14.5%
10/29 Q3/2019 9/30/2019 EPS 0.070 ZacksConsensus 0.040 ActVsEst 0.030 - Beat 11.0%
4/28 Neogenomics Inc (NEO) Q1 2020 Earnings Call Transcript [The Motley Fool] 10.9%
3/1 NeoGenomics, Inc. Just Beat EPS By 122%: Here's What Analysts Think Will Happen Next [Yahoo! Finance News] 5.9%
11/22 Form 4 NEOGENOMICS INC For: Nov 20 Filed by: JONES STEVEN C 5.2%
3/18 NeoGenomics, Inc. (NASDAQ: NEO) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.1%
2/27 NeoGenomics, Inc. (NEO) CEO Doug VanOort on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.1%
2/28 NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference 5.0%
5/22 Form 8-K NEOGENOMICS INC For: May 22 4.3%
10/3 NeoGenomics (NEO) Presents At Cantor Healthcare Conference - Slideshow [Seeking Alpha] 3.9%
10/29 Q3/2019 9/30/2019 EPS 0.070 ZacksConsensus 0.040 ActVsEst 0.030 - Beat 11.0%
4/28 Neogenomics Inc (NEO) Q1 2020 Earnings Call Transcript [The Motley Fool] 10.9%
3/1 NeoGenomics, Inc. Just Beat EPS By 122%: Here's What Analysts Think Will Happen Next [Yahoo! Finance News] 5.9%
11/22 Form 4 NEOGENOMICS INC For: Nov 20 Filed by: JONES STEVEN C 5.2%
3/18 NeoGenomics, Inc. (NASDAQ: NEO) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.1%
2/27 NeoGenomics, Inc. (NEO) CEO Doug VanOort on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.1%
2/28 NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference 5.0%
5/22 Form 8-K NEOGENOMICS INC For: May 22 4.3%
10/3 NeoGenomics (NEO) Presents At Cantor Healthcare Conference - Slideshow [Seeking Alpha] 3.9%
TOP News Decliners
4/29
NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
-13.0%
4/28 Form 8-K NEOGENOMICS INC For: Apr 28 -11.0%
4/3 NeoGenomics Integrates HALO(R) From Indica Labs -10.3%
2/27 Q4/2019 12/31/2019 EPS 0.100 ZacksConsensus 0.050 ActVsEst 0.050 - Beat -10.0%
4/21 NeoGenomics, Inc. (NASDAQ: NEO) is now covered by analysts at Stephens. They set an "overweight" rating on the stock. -6.7%
5/20 Form 8-K NEOGENOMICS INC For: May 20 -5.8%
10/30 NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Needham & Company LLC from $27.00 to $29.00. They now have a "buy" rating on the stock. -5.6%
6/10 Form 4 NEOGENOMICS INC For: Jun 06 Filed by: Johnson Kevin C -5.3%
2/5 NeoGenomics Announces Leadership Appointments -5.2%
4/1 NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020 -4.8%
4/28 Form 8-K NEOGENOMICS INC For: Apr 28 -11.0%
4/3 NeoGenomics Integrates HALO(R) From Indica Labs -10.3%
2/27 Q4/2019 12/31/2019 EPS 0.100 ZacksConsensus 0.050 ActVsEst 0.050 - Beat -10.0%
4/21 NeoGenomics, Inc. (NASDAQ: NEO) is now covered by analysts at Stephens. They set an "overweight" rating on the stock. -6.7%
5/20 Form 8-K NEOGENOMICS INC For: May 20 -5.8%
10/30 NeoGenomics, Inc. (NASDAQ: NEO) had its price target raised by analysts at Needham & Company LLC from $27.00 to $29.00. They now have a "buy" rating on the stock. -5.6%
6/10 Form 4 NEOGENOMICS INC For: Jun 06 Filed by: Johnson Kevin C -5.3%
2/5 NeoGenomics Announces Leadership Appointments -5.2%
4/1 NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020 -4.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: